{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:11:42Z","timestamp":1789809102464,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pharep.2018.02.008","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T13:42:05Z","timestamp":1518010925000},"page":"705-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice"],"prefix":"10.1007","volume":"70","author":[{"given":"Xiang-Fan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2018.02.008_bib0005","first-page":"1230","article-title":"Pyrroloquinoline quinone prevents testosterone deficiency-induced osteoporosis by stimulating osteoblastic bone formation and inhibiting osteoclastic bone resorption","volume":"9","author":"Wu","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.pharep.2018.02.008_bib0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s001980070037","article-title":"Effects of body size and skeletal site on the estimated prevalence of osteoporosis in women and men","volume":"11","author":"Melton","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharep.2018.02.008_bib0015","doi-asserted-by":"crossref","first-page":"25206","DOI":"10.1038\/srep25206","article-title":"Prevalence of osteoporosis and low bone mass in older Chinese population based on bone mineral density at multiple skeletal sites","volume":"6","author":"Lu","year":"2016","journal-title":"Sci Rep"},{"issue":"43","key":"10.1016\/j.pharep.2018.02.008_bib0020","doi-asserted-by":"crossref","first-page":"e8294","DOI":"10.1097\/MD.0000000000008294","article-title":"Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men: a cross-sectional study in Gansu province, Northwestern of China","volume":"96","author":"Tian","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharep.2018.02.008_bib0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00002512-200522090-00003","article-title":"Male osteoporosis: new trends in diagnosis and therapy","volume":"22","author":"Kamel","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pharep.2018.02.008_bib0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ecl.2005.07.009","article-title":"Pathophysiology of age-related bone loss and osteoporosis","volume":"34","author":"Khosla","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.pharep.2018.02.008_bib0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mehy.2011.04.004","article-title":"The effect of renin angiotensin system on tamoxifen resistance","volume":"77","author":"Namazi","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pharep.2018.02.008_bib0040","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1097\/HJH.0b013e32834bbb4d","article-title":"Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition","volume":"29","author":"Inaba","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharep.2018.02.008_bib0045","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1074\/jbc.M807610200","article-title":"Angiotensin II type 2 receptor blockade increases bone mass","volume":"284","author":"Izu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2018.02.008_bib0050","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3892\/mmr.2014.1978","article-title":"Role of the local bone renin angiotensin system in steroid induced osteonecrosis in rabbits","volume":"9","author":"Zhang","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.pharep.2018.02.008_bib0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1359\/jbmr.081006","article-title":"Activation of renin-angiotensin system induces osteoporosis independently of hypertension","volume":"24","author":"Asaba","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharep.2018.02.008_bib0060","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1271\/bbb.120123","article-title":"Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice","volume":"76","author":"Gu","year":"2012","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.pharep.2018.02.008_bib0065","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1440-1797.2012.01656.x","article-title":"Early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice","volume":"17","author":"Gu","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.pharep.2018.02.008_bib0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00774-013-0500-7","article-title":"Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes","volume":"32","author":"Diao","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.pharep.2018.02.008_bib0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1157\/13095095","article-title":"Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril","volume":"127","author":"Garc\u00eda-Testal","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.pharep.2018.02.008_bib0080","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","article-title":"Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese","volume":"38","author":"Lynn","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.pharep.2018.02.008_bib0085","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/hr.2009.99","article-title":"Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats","volume":"32","author":"Shimizu","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pharep.2018.02.008_bib0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biopha.2017.05.062","article-title":"ACE-2\/Ang1-7\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats","volume":"92","author":"Abuohashish","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharep.2018.02.008_bib0095","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","article-title":"Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation \u2013 role of a local renin-angiotensin system","volume":"159","author":"Garcia","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2018.02.008_bib0100","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.25011\/cim.v38i4.24261","article-title":"The effects of the angiotensin converting enzyme inhibitor enalapril and the angiotensin II type 1 receptor blocker losartan on fracture healing in rats","volume":"38","author":"Bayar","year":"2015","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.pharep.2018.02.008_bib0105","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-011-1831-7","article-title":"Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?","volume":"23","author":"Kwok","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharep.2018.02.008_bib0110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00774-012-0363-3","article-title":"The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese","volume":"30","author":"Zhang","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.pharep.2018.02.008_bib0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2017.01.029","article-title":"Differential response of bone and kidney to ACEI in db\/db mice: a potential effect of captopril on accelerating bone loss","volume":"97","author":"Zhang","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.pharep.2018.02.008_bib0120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10072-014-2040-x","article-title":"Effect of ACE inhibitors and AT1 receptor antagonists on pentylenetetrazole-induced convulsions in mice","volume":"36","author":"\u0141ukawski","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.pharep.2018.02.008_bib0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JND-150099","article-title":"The angiotensin converting enzyme inhibitor lisinopril improves muscle histopathology but not contractile function in a mouse model of Duchenne muscular dystrophy","volume":"2","author":"Lowe","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.pharep.2018.02.008_bib0130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jdiacomp.2016.08.016","article-title":"Involvement of skeletal renin-angiotensin system and kallikrein-kinin system in bone deteriorations of type 1 diabetic mice with estrogen deficiency","volume":"30","author":"Zhang","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.pharep.2018.02.008_bib0135","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00198-015-3348-y","article-title":"Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice","volume":"27","author":"Zhang","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharep.2018.02.008_bib0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1074248416686188","article-title":"ACE phenotyping as a guide toward personalized therapy with ACE inhibitors","volume":"22","author":"Danilov","year":"2017","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.pharep.2018.02.008_bib0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pharep.2018.02.008_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phrs.2014.02.007","article-title":"Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD)","volume":"81","author":"Impellizzeri","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2018.02.008_bib0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00774-010-0209-9","article-title":"Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts","volume":"29","author":"Liu","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.pharep.2018.02.008_bib0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12020-014-0167-4","article-title":"Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis","volume":"46","author":"Ghosh","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.pharep.2018.02.008_bib0165","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4149\/gpb_2016015","article-title":"A comparative study between the effect of 17-\u03b2 estradiol and angiotensin converting enzyme inhibitor on osteoporosis in ovariectomized rats","volume":"35","author":"Alaam","year":"2016","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.pharep.2018.02.008_bib0170","first-page":"1604","article-title":"Local bone interaction between renin-angiotensin system and kallikrein-kinin system in diabetic rat","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pharep.2018.02.008_bib0175","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/jcp.24668","article-title":"Bradykinin regulates osteoblast differentiation by Akt\/ERK\/NF\u03baB signaling axis","volume":"229","author":"Srivastava","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharep.2018.02.008_bib0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3892\/ijmm.2016.2457","article-title":"Bradykinin receptors and EphB2\/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice","volume":"37","author":"Wu","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.pharep.2018.02.008_bib0185","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/HYPERTENSIONAHA.117.09815","article-title":"Inhibition of aneurysm progression by direct renin inhibition in a rabbit model","volume":"70","author":"Miyake","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.pharep.2018.02.008_bib0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/ijpvm.IJPVM_322_16","article-title":"Effect of angiotensin-converting enzyme inhibitor on cardiac fibrosis and oxidative stress status in lipopolysaccharide-induced inflammation model in rats","volume":"8","author":"Abareshi","year":"2017","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.pharep.2018.02.008_bib0195","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/endo.139.2.5717","article-title":"Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor beta in rat bone, and reduction is prevented by testosterone","volume":"139","author":"Gill","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharep.2018.02.008_bib0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00408-015-9688-8","article-title":"Profibrosing effect of angiotensin converting enzyme inhibitors in human lung fibroblasts","volume":"193","author":"D\u00edaz-Pi\u00f1a","year":"2015","journal-title":"Lung"},{"key":"10.1016\/j.pharep.2018.02.008_bib0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10557-010-6278-0","article-title":"Rationale for combining a direct renin inhibitor with other renin- angiotensin system blockers. Focus on aliskiren and combinations","volume":"25","author":"Siragy","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pharep.2018.02.008_bib0210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MJT.0b013e3182068da5","article-title":"Clinical role of direct renin inhibition in hypertension","volume":"19","author":"Taylor","year":"2012","journal-title":"Am J Ther"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017305820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017305820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:32Z","timestamp":1752611852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.02.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1734114017305820"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.02.008","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}